Summary & Overview
HCPCS C9603: Coronary Atherectomy with Drug-Eluting Stent, Additional Branch
HCPCS Level II code C9603 represents a percutaneous transluminal coronary atherectomy with placement of a drug-eluting intracoronary stent and coronary angioplasty when performed, billed specifically for each additional branch of a major coronary artery beyond the primary site. This code captures complex, branch-specific interventional work during coronary revascularization and matters nationally because it affects how multi-branch procedures are itemized and reimbursed across hospital and outpatient interventional settings. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn the clinical context for use of C9603, how it relates to primary branch procedures and associated coding, and which service settings typically apply. The publication summarizes benchmark considerations and payer coverage patterns, highlights policy and billing nuances that affect multi-branch coronary interventions, and outlines related coding to support accurate claim submission. The goal is to provide concise operational and clinical context for revenue cycle, interventional cardiology teams, and policy analysts working with complex coronary procedure coding.
Billing Code Overview
HCPCS Level II code C9603 describes a percutaneous transluminal coronary atherectomy performed in conjunction with placement of a drug-eluting intracoronary stent, with coronary angioplasty when performed, billed for each additional branch of a major coronary artery (listed separately in addition to the code for the primary procedure).
Service type: Interventional coronary revascularization procedure
Typical site of service: Hospital cardiac catheterization laboratory or outpatient interventional cardiology suite
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with a history of hypertension, hyperlipidemia, and known multivessel coronary artery disease presents to the emergency department with chest pain, elevated cardiac biomarkers, and electrocardiographic changes concerning for acute myocardial infarction. Coronary angiography demonstrates significant stenoses in the left anterior descending artery and a large diagonal branch. Primary percutaneous coronary intervention is performed using percutaneous transluminal coronary atherectomy to debulk calcified plaque, followed by placement of a drug-eluting intracoronary stent and adjunctive balloon angioplasty as needed. C9603 is reported for the additional treated branch beyond the primary vessel. Typical workflow includes pre-procedure consent and antiplatelet loading, vascular access (radial or femoral) in the cardiac catheterization laboratory, intraprocedural imaging and hemodynamic monitoring, use of atherectomy device for plaque modification, stent deployment, assessment of flow and residual stenosis, and post-procedure monitoring in a coronary care unit or step-down unit. Typical site of service is an inpatient or outpatient cardiac catheterization laboratory within a hospital or ambulatory surgical center. The typical service type is invasive therapeutic interventional cardiology (percutaneous coronary intervention) for multivessel coronary artery disease or acute myocardial infarction.
Coding Specifications
- Below are clinically relevant modifiers for
C9603and when to use them.
| Modifier | Description | When to Use |
|---|